LG 101506: High-Purity RXR Modulator for Precise Nuclear Receptor Research

Executive Summary: LG 101506 is a research-grade, small molecule RXR modulator with 98% purity, optimized for dissecting RXR signaling in metabolism, cancer, and immune regulation studies (APExBIO). It offers high solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml), enhancing experimental flexibility and reproducibility. The compound is not intended for diagnostic or clinical use, and its stability is assured by recommended -20°C storage and specialized shipping conditions. RXR signaling is implicated in the modulation of nuclear receptor-related disease models, including metabolic syndromes and cancer immunobiology (Zhang et al., 2022). LG 101506 enables precise manipulation of RXR pathways, offering translational insights for metabolic and immune-cold tumor research.

Biological Rationale

Retinoid X Receptors (RXRs) are nuclear receptors that function as transcriptional regulators in diverse physiological processes, including lipid metabolism, glucose homeostasis, and immune response. RXR forms heterodimers with other nuclear receptors such as PPAR, LXR, and FXR, modulating gene expression in response to endogenous and exogenous ligands (Chellampain, 2023). RXR signaling has emerged as a critical axis in cancer biology, metabolic disease models, and immune checkpoint regulation. Recent evidence highlights the relevance of RXR modulation in overcoming immune resistance in triple-negative breast cancer (TNBC) and enhancing anti-tumor T cell immunity (Zhang et al., 2022).

Mechanism of Action of LG 101506

LG 101506 is a synthetic RXR modulator with the chemical name (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid. Its molecular weight is 420.53 g/mol. LG 101506 binds to RXR with high affinity, altering the receptor’s conformation and influencing heterodimerization with partner nuclear receptors. This leads to context-dependent gene regulation in metabolic pathways, immune cell differentiation, and tumor microenvironment modulation (ERBB1, 2023). Unlike pan-agonists, LG 101506 provides pathway-selective modulation, allowing researchers to dissect RXR-specific functions with reduced off-target activity.

Evidence & Benchmarks

• LG 101506 demonstrates 98% analytical purity by HPLC, ensuring minimal confounding by impurities (APExBIO).
• Solubility in DMSO reaches 42.05 mg/ml, enabling high-concentration stock solutions for cell-based and biochemical assays (APExBIO).
• RXR modulators such as LG 101506 are instrumental in studies dissecting the crosstalk between RXR and immune checkpoint pathways, including PD-L1 stabilization and degradation in TNBC models (Zhang et al., 2022).
• Post-translational modifications of immune checkpoints like PD-L1, regulated in part by nuclear receptor pathways, affect T cell-mediated tumor clearance (Zhang et al., 2022).
• LG 101506 outperforms generalist RXR ligands in experimental reproducibility when used under recommended storage and handling protocols (VSV-G Peptide, 2023).

This article updates prior summaries such as Phostag.net by providing detailed mechanistic and benchmark data for LG 101506 in immune-cold disease models.

Applications, Limits & Misconceptions

LG 101506 is suited for research in:

• RXR signaling pathway research in metabolic and cancer biology (VSV-G Peptide, 2023).
• Manipulation of nuclear receptor-related disease models, including studies of immune checkpoint regulation and metabolic syndrome.
• Investigation of post-translational modification (PTM) regulatory mechanisms in cancer immunity (Zhang et al., 2022).

Common Pitfalls or Misconceptions

• LG 101506 is not intended for diagnostic or human therapeutic use; it is strictly for research applications (APExBIO).
• Long-term storage of LG 101506 solutions is not recommended; fresh aliquots should be used to maintain compound integrity.
• Its efficacy is dependent on the correct storage temperature (-20°C) and shipping conditions (blue or dry ice).
• LG 101506 does not substitute for pan-RXR agonists in studies requiring broad nuclear receptor activation.
• The compound’s effects are context- and assay-dependent; extrapolation to in vivo or clinical outcomes requires validation.

For a broader overview of LG 101506’s role in nuclear receptor signaling, see this Chempaign article, which this dossier extends by detailing application boundaries and workflow controls.

Workflow Integration & Parameters

To maximize reproducibility, LG 101506 should be dissolved in DMSO or ethanol at concentrations up to 42.05 mg/ml and 21.03 mg/ml, respectively. Avoid repeated freeze-thaw cycles. Prepare working solutions immediately prior to experiments. Store powder at -20°C in a desiccated, light-protected environment. Shipping from APExBIO uses blue ice (for small molecules) or dry ice (for modified nucleotides) to maintain stability. Use in cell-based, biochemical, or molecular assays focused on RXR signaling, PTM of immune checkpoints, or metabolic regulation (APExBIO).

This article clarifies and expands on integration protocols compared to VSV-G Peptide, highlighting strict storage and handling parameters for LG 101506.

Conclusion & Outlook

LG 101506 (SKU: B7414) provides a robust, high-purity tool for RXR pathway research in metabolism, cancer, and immune checkpoint biology. Its defined solubility and storage profile enable controlled, reproducible experiments. The compound’s selectivity supports mechanistic dissection of RXR functions and post-translational regulation of proteins such as PD-L1 in disease models. Future directions include leveraging LG 101506 in combinatorial studies to refine our understanding of nuclear receptor signaling and therapeutic resistance (Zhang et al., 2022).

For product specifications and ordering, visit the LG 101506 page at APExBIO.